Keefe, R., Seidman, L. J., Christensen, B., Hamer, R. M., Yurgelun-Todd, D., Lewine, R., … Lieberman, J. A. (2003). Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis. In Schizophrenia Research (Vol. 60, pp. 289–289). Elsevier BV. https://doi.org/10.1016/s0920-9964(03)80477-2

Keefe, R., L. J. Seidman, B. Christensen, R. M. Hamer, D. Yurgelun-Todd, R. Lewine, M. Sitskoorn, T. Sharma, M. Tohen, and J. A. Lieberman. “Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis.” In Schizophrenia Research, 60:289–289. Elsevier BV, 2003. https://doi.org/10.1016/s0920-9964(03)80477-2.

Keefe R, Seidman LJ, Christensen B, Hamer RM, Yurgelun-Todd D, Lewine R, et al. Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis. In: Schizophrenia Research. Elsevier BV; 2003. p. 289–289.

Keefe, R., et al. “Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis.” Schizophrenia Research, vol. 60, no. 1, Elsevier BV, 2003, pp. 289–289. Crossref, doi:10.1016/s0920-9964(03)80477-2.

Keefe R, Seidman LJ, Christensen B, Hamer RM, Yurgelun-Todd D, Lewine R, Sitskoorn M, Sharma T, Tohen M, Lieberman JA. Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis. Schizophrenia Research. Elsevier BV; 2003. p. 289–289.